7-methyl-2-phenylimidazo[1,2-{a}]pyridin-3-amine, 95.0%, 250mg

2H-Imidazo[4,5-c]quinolin-2-one, 8-[6-[3-(dimethylamino)propoxy]-3-pyridinyl]-1,3-dihydro-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-, 25mg

(S)-1-(4-Bromophenyl)ethanamine hydrochloride, 95.0%, 10g

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 30 m, Ø-Innen 0,32 mm, Filmd. 0,35 µm, 1 Stück

(3S)-1-Benzhydryl-2,2-dimethyl-azetidin-3-ol, 98%, 5g

3-(tert-Butyl)-4-(2,6-dimethoxy-3,5-dimethylphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 100mg

4-(3,5-Dimethylisoxazol-4-yl)benzaldehyde, 95.0%, 1g

3-Chloro-2-isopropyl-5-methylpyrazine, 97%, 100mg

5-AMINONONANE, 95.0%, 1g

2-(2,4-Dichloro-phenylamino)-thiazole-4-carboxylic acid, 1g

3-Z-Amino-cyclobutanone, 95.0%, 10g

4-(2-fluorobenzoyl)-8-methyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

Crotonoyl Chloride (cis- and trans- mixture)>95.0%(GC)25g